ReNeu: A Pivotal Phase 2b Trial of Mirdametinib in Children and Adults With Neurofibromatosis Type 1 (NF1)-Associated Symptomatic Plexiform Neurofibroma (PN) (S29.003)

Shuhaiber, H., Moertel, C., Hirbe, A., Viskochil, D., Sidhu, A., Bielamowicz, K., … Babovic-Vuksanovic, D. (2025). ReNeu: A Pivotal Phase 2b Trial of Mirdametinib in Children and Adults With Neurofibromatosis Type 1 (NF1)-Associated Symptomatic Plexiform Neurofibroma (PN) (S29.003). Neurology, 104(7_Supplement_1). https://doi.org/10.1212/wnl.0000000000209005